喘息予防薬の世界市場:ICS/LABA配合剤、免疫抑制薬、ロイコトリエン拮抗薬、マスト細胞安定化剤、吸入ステロイド薬...市場調査レポートについてご紹介

【英文タイトル】Global Preventive Asthma Drugs Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Product profiles
Accolate
Pulmicort
Symbicort
Xolair
Advair
Anoro Ellipta
Arnuity Ellipta
Breo Ellipta
Flovent
Serevent
Ventolin
Asmanex
Foradil
Dulera
Singulair

PART 06: Disease overview
Understanding the disease
Symptoms
Pathophysiology
Epidemiology
Diagnosis
Management

PART 07: Pipeline Portfolio

PART 08: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 09: Market segmentation by class of drug

PART 10: ICS/LABA combination
Global ICS/LABA combination market

PART 11: Immuno-suppressants
Global immunosuppressants market

PART 12: Leukotriene antagonists
Global leukotriene antagonists market

PART 13: Mast cell stabilizers
Global mast cell stabilizers market

PART 14: Inhaled corticosteroids
Global inhaled corticosteroids market

PART 15: Geographical segmentation
Global preventive asthma drugs market by geography 2014-2019
Preventive asthma drugs market in Americas
Preventive asthma drugs market in EMEA
Preventive asthma drugs market in APAC

PART 16: Market drivers

PART 17: Impact of drivers

PART 18: Market challenges

PART 19: Impact of drivers and challenges

PART 20: Market trends

PART 21: Vendor landscape
Competitive scenario
Other and future prominent vendors

PART 22: Key vendor analysis
AstraZeneca
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Novartis

PART 23: Appendix
List of abbreviations

PART 24: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Major diagnostic procedures for asthma
Exhibit 03: Major drugs under development for asthma
Exhibit 04: Global preventive asthma drugs market ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of global preventive asthma drugs market by class of drug
Exhibit 07: Segmentation of global preventive asthma drugs market by class of drug 2014
Exhibit 08: Global preventive asthma drugs market: Market share by class of drug 2014-2019 ($ millions)
Exhibit 09: Global ICS/LABA combination market 2014-2019 ($ millions)
Exhibit 10: Global immunosuppressants market 2014-2019 ($ millions)
Exhibit 11: Global leukotriene antagonists market 2014-2019 ($ millions)
Exhibit 12: Global mast cell stabilizers market 2014-2019 ($ millions)
Exhibit 13: Global corticosteroids market 2014-2019 ($ millions)
Exhibit 14: Global preventive asthma drugs market by geography 2014
Exhibit 15: Global preventive asthma drugs market: Market share by region 2014-2019 ($ millions)
Exhibit 16: Preventive asthma drugs market in Americas 2014-2019 ($ millions)
Exhibit 17: Preventive asthma drugs market in EMEA 2014-2019 ($ millions)
Exhibit 18: Impact of drivers
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Sales of Pulmicort in US 2011-2014 ($ millions)
Exhibit 21: Global sales of Pulmicort 2011-2014 ($ millions)
Exhibit 22: AstraZeneca: Key takeaways
Exhibit 23: Sales of Xolair in the US 2011-2014 ($ millions)
Exhibit 24: F. Hoffmann-La Roche: Key takeaways
Exhibit 25: Global sales of Ventolin 2011-2014 ($ millions)
Exhibit 26: Global sales of Flovent 2011-2014 ($ millions)
Exhibit 27: Global sales of Advair 2011-2014 ($ millions)
Exhibit 28: Global sales of Serevent 2011-2014 ($ millions)
Exhibit 29: GlaxoSmithKline: Key takeaways
Exhibit 30: Global sales of Asmanex 2011-2013 ($ millions)
Exhibit 31: Global sales of Dulera 2011-2013 ($ millions)
Exhibit 32: Global sales of Singulair 2011-2013 ($ millions)
Exhibit 33: Merck: Key takeaways
Exhibit 34: Sales of Xolair (ex-US) 2011-2014 ($ millions)
Exhibit 35: Key takeaways: Novartis
Exhibit 36: AstraZeneca: Business segmentation by revenue 2014
Exhibit 37: AstraZeneca: Business segmentation by revenue 2013 and 2014
Exhibit 38: AstraZeneca: Geographical segmentation by revenue 2014


【レポート販売概要】

■ タイトル:喘息予防薬の世界市場:ICS/LABA配合剤、免疫抑制薬、ロイコトリエン拮抗薬、マスト細胞安定化剤、吸入ステロイド薬
■ 英文:Global Preventive Asthma Drugs Market 2015-2019
■ 発行日:2015年10月7日
■ 調査会社:Technavio
■ 商品コード:IRTNTR7196
■ 調査対象地域:グローバル
  • ドイツの診断市場::市場動向と展望
    This new report from Venture Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:     -  Blood Banking      -  Cancer      -  Chemistry &nb …
  • 世界のアルコール飲料市場2015
    The Global Alcoholic Drinks Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Alcoholic Drinks industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Alcoholic Drinks market analysis is provided for the international markets including development trends, …
  • 世界の産業用LED照明市場(2014-2018)
    About LEDs An LED is a semiconductor diode that emits visible light when voltage is applied to it. A diode is an electronic component that allows electricity to flow solely in one direction. LEDs were initially used as indicators in different applications. Later, they were used to display numbers on electronic meters and sign boards. Currently, LEDs have penetrated nearly every application that ma …
  • 統合エンドポイント管理の世界市場予測(~2020)
    The global unified endpoint management market is expected to grow from USD 624.9 Million in 2015 to USD 3.73 Billion by 2020, at a CAGR of 42.9% during the forecast period. Proliferation of mobile device adoption in the enterprises such as smartphones, tablets, and other wearable devices brings various daunting challenges around security, privacy, speed-to-market, and to manage the information tha …
  • 肝臓癌治療薬の世界市場2019-2023
    About this market Liver cancer is among the leading causes of cancer-related deaths, globally. The increase in incidence of risk factors like hepatitis B and C and underlying cirrhosis will lead to the rise in risk of liver cancer depending on the etiology. The increase in incidence of life-style diseases like fatty liver is a major risk factor for liver cancer. Furthermore, the increase in incide …
  • 世界の政府部門におけるバイオメトリクス認証支出市場
    About biometrics spending in the government sector Security of data and assets has been a key concern for enterprises, banks, government organizations, telecommunications, hospitals, as well as individuals. Keys, identity badges, and numeric keypads were previously being used to prevent unauthorised access. Technological advancements resulted in the introduction of two-factor authentication, where …
  • アンチエイジング製品および治療の世界市場2015-2022
    According to Stratistics MRC, the Global Anti-Aging Products and Therapies market is accounted for $127.9 billion in 2015 and is expected to reach $237.8 billion by 2022 growing at a CAGR of 9.2% from 2015 to 2022. Factors such as increasing demand for anti-aging hair care products, rise in urbanization and per capita income, advancement in cosmetic technologies, Laser/Energy-Based Cosmetic Treatm …
  • UAV(無人機) 飛行訓練及びシミュレーションの世界市場2017-2021
    About UAV Flight Training and Simulation Unmanned aerial vehicles (UAVs) are also called as remotely piloted aircraft by the International Civil Aviation Organization (ICAO) as they are controlled remotely either by a pilot at a ground station or by on-board computers. They are also commonly referred to as drones and host various types of payloads that enable the aircraft to easily navigate, commu …
  • 血友病A・血友病Bの組換え因子補充療法:世界の薬剤市場予測・分析
    PharmaPoint: Hemophilia A and B Recombinant Factor Replacement Therapy - Global Drug Forecast and Market Analysis to 2024 Summary Congenital hemophilia A and B are bleeding disorders that are caused by genetic X-linked deficiencies in the blood clotting Factors VIII and IX, respectively. Hemophilia manifests as mild, moderate, or severe inability to form clots, depending upon the endogenous levels …
  • 世界の血液検査及びフローサイトメトリー(医療機器)市場:サプライヤーシェア及び市場予測
    Complete report $32,200.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.SummaryThis comprehensive seven-country report contains 700 pages, 250 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years.  The rep …
  • NFCトランザクション(支払処理)の世界市場
    About NFC Transaction NFC is a standard short-range connectivity, which uses high frequency wireless communication technology for peer-to-peer communication between two devices. End-users can use this technology to transfer data from one devices to another. NFC technology has revolutionized the ways in which people access, use data and information. NFC-enabled devices can be used for mobile paymen …
  • Ecopetrol S.A.:石油・ガスの開発・生産動向及びコスト分析– Q1, 2013
    Ecopetrol S.A. Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Ecopetrol S.A. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key opera …
  • 調剤自動化装置の世界市場:自動倉庫システム、自動包装・ラベルシステム、錠剤計数器、自動調合デバイス
    About Global Pharmacy Automation Market Pharmacy automation system is an effective tool to minimize prescription errors and ensure patient safety. It is a system to automate workflow process and eliminate medication errors during packaging and dispensing in the field of medicine and healthcare. Pharmacy automation involves medicine counting, mixing and measuring liquids and powders for compounding …
  • 酵母成分の世界市場:アプリケーション別(飼料、食品)、種類別(自己分解物、抽出物、ベータグルカン、誘導体)、ベンダー別、セグメント予測
    The global yeast ingredients market size is expected to reach USD 3.5 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 8.0% during the forecast period. Rising usage of yeast ingredients in the food industry, coupled with government initiatives to promote use of these ingredients in food products, is expected to boost the growth of the market over the fo …
  • ベータグルカン市場動向
    Product Synopsis This forecast report on Beta-Glucans covers an in-depth analysis of Beta-Glucan ingredients manufacturers and ingredients characteristics in relation to raw material use and extraction methods. The report investigates health benefits of Beta-Glucans and their regulatory status. The use for this ingredient category for food and beverage products is discussed and product case storie …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。